Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis

Shilan Zhang, Sabeeta Kapoor, Chakrapani Tripathi, Jorge Tovar Perez, Nivedhitha Mohan, Wan Mohaiza Dashwood, Ke Zhang, Praveen Rajendran, Roderick Dashwood

Research output: Contribution to journalArticlepeer-review

Abstract

ACE2 overexpression in colorectal cancer patients might increase susceptibility to SARS-CoV-2 infection. We report that knockdown, forced overexpression, and pharmacologic inhibition in human colon cancer cells targeted ACE2-BRD4 crosstalk to mediate marked changes in DNA damage/repair and apoptosis. In colorectal cancer patients for whom high ACE2 plus high BRD4 expression is predictive of poor survival, pan-BET inhibition would need to consider proviral/antiviral actions of different BET proteins during SARS-CoV-2 infection.

Original languageEnglish (US)
Article number20
Journalnpj Precision Oncology
Volume7
Issue number1
DOIs
StatePublished - Dec 2023

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis'. Together they form a unique fingerprint.

Cite this